Introducing PIONEER: Our Global Natural History Study for POLG Disease
Introducing PIONEER: Our Global Natural History Study for POLG Disease We’re excited to share a project that has been at the heart of our work at The POLG Foundation for […]
Introducing PIONEER: Our Global Natural History Study for POLG Disease We’re excited to share a project that has been at the heart of our work at The POLG Foundation for […]
From genetic diagnosis to treatment: The POLG Foundation at the Oxford Harrington Symposium Ron Harrington, Our co-founder, Julie de Luxembourg, Jill Harrington, Nancy Harrington, Lord Cameron at Trinity College Oxford […]
Today, a new paper by Hirano et al. has been published into the use of nucleoside therapy for mitochondrial DNA depletion/deletion syndrome (MDDS). The full article can be read here. […]
It was an honour for the POLG Foundation team to attend EUROMIT 2026, the world’s largest international conference dedicated to mitochondrial medicine and research, held this year in the beautiful […]
26 June 2026 – The POLG Foundation brought together patients, families, researchers, clinicians, industry partners and advocates from around the world for its second POLG Virtual Summit, showcasing the latest […]
16 December 2025 By Biotech Newswire GENEVA, Switzerland, December 16, 2025 / Biotech Newswire In a heartfelt tribute that has evolved into a lasting legacy, The POLG Foundation—with the generous […]
On October 21, 2024, The POLG Foundation hosted its inaugural networking event, An Evening with The POLG Foundation, in New York City. The event was organized by our New York-based […]
March 2024 The POLG Foundation Board of Directors and leadership team are delighted to announce Luca Bolliger, Ph.D., has been named a member TPF’s Scientific Advisory Committee. The SAB, chaired […]